Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2019

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2019

Summary

latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2019, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape.

Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver or abdomen, swollen feet and ankles and weight gain. There are two types of heart failure including systolic heart failure (left ventricle loses its ability to contract normally) and diastolic heart failure (left ventricle loses its ability to relax normally). The predisposing factors include high blood pressure, diabetes, sleep apnea, alcohol use and irregular heartbeats. Treatment includes surgery, vasodilator, beta blockers and diuretics.

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Congestive Heart Failure (Heart Failure) (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 4, 11, 29, 22, 3, 76 and 21 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 20 and 4 molecules, respectively.

Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Congestive Heart Failure (Heart Failure) (Cardiovascular).
- The pipeline guide reviews pipeline therapeutics for Congestive Heart Failure (Heart Failure) (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Congestive Heart Failure (Heart Failure) (Cardiovascular) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Congestive Heart Failure (Heart Failure) (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Congestive Heart Failure (Heart Failure) (Cardiovascular)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Congestive Heart Failure (Heart Failure) (Cardiovascular).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Introduction
Congestive Heart Failure (Heart Failure) - Overview
Congestive Heart Failure (Heart Failure) - Therapeutics Development
Congestive Heart Failure (Heart Failure) - Therapeutics Assessment
Congestive Heart Failure (Heart Failure) - Companies Involved in Therapeutics Development
Congestive Heart Failure (Heart Failure) - Drug Profiles
Congestive Heart Failure (Heart Failure) - Dormant Projects
Congestive Heart Failure (Heart Failure) - Discontinued Products
Congestive Heart Failure (Heart Failure) - Product Development Milestones
Appendix

List Of Tables

Number of Products under Development for Congestive Heart Failure (Heart Failure), H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019 (Contd..1), H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Products under Development by Universities/Institutes, H2 2019 (Contd..1), H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Target, H2 2019 (Contd..1), H2 2019
Number of Products by Stage and Target, H2 2019 (Contd..2), H2 2019
Number of Products by Stage and Target, H2 2019 (Contd..3), H2 2019
Number of Products by Stage and Target, H2 2019 (Contd..4), H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..1), H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..2), H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..3), H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..4), H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by 4TEEN4 Pharmaceuticals GmbH, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Actelion Pharmaceuticals Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Adrenomed AG, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by AgeX Therapeutics Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Amgen Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Anchored Rsk3 Inhibitors LLC, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Araim Pharmaceuticals Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by ARCA biopharma Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Arena Pharmaceuticals Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Armaron Bio Pty Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Armgo Pharma Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Ascelegen Therapeutics Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Ascendia Pharmaceuticals LLC, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Astellas Pharma Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by AstraZeneca Plc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Athersys Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Bayer AG, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by BEAT BioTherapeutics Corp, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Betagenon AB, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by BioCardia Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by BioStem Technologies Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by BlueRock Therapeutics, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Boehringer Ingelheim International GmbH, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Bristol-Myers Squibb Co, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by C&C BioPharma LLC, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Capricor Therapeutics Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Cardiol Therapeutics Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Cardior Pharmaceuticals GmbH, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Cardiora Pty Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by CCRP Therapeutics GmbH, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Celixir Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by CuronBiotech Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Cyclerion Therapeutics Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Daiichi Sankyo Co Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by DepYmed Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Elevian Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Ethicare GmbH, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Exscien Corp, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by F. Hoffmann-La Roche Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by G3 Pharmaceuticals Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by GBSciences Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Gmax Biopharm Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Heartseed Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Hemostemix Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by iHeart Japan Corp, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Immunwork Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Innolife Co Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Innopharmax Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Inserm Transfert SA, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Intra-Cellular Therapies Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by IsletOne AB, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Japan Tobacco Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by JT Pharmaceuticals Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Juventas Therapeutics Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Katakura Industries Co Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by KBP BioSciences Co Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by La Jolla Pharmaceutical Company, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Larix Bioscience LLC, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Lead Discovery Center GmbH, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Les Laboratoires Servier SAS, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Lexicon Pharmaceuticals Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Merck & Co Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Mesoblast Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Mirabilis Therapeutics BV, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Miragen Therapeutics Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Mitsubishi Tanabe Pharma Corp, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Moderna Therapeutics Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by MyoKardia Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Nanjing Transthera Biosciences Co Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by NanoCor Therapeutics Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by NeoProgen Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Novartis AG, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by NovoMedix LLC, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Olatec Therapeutics LLC, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Orion Corp, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Otsuka Holdings Co Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Oxstem Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Oxydend Therapeutics Pty Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Palatin Technologies Inc, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Paradigm Biopharmaceuticals Ltd, H2 2019
Congestive Heart Failure (Heart Failure) - Pipeline by Pfizer Inc, H2 2019

List Of Figures

Number of Products under Development for Congestive Heart Failure (Heart Failure), H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Top 10 Routes of Administration, H2 2019
Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Number of Products by Top 10 Molecule Types, H2 2019
Number of Products by Stage and Top 10 Molecule Types, H2 2019

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available